sella
play

SELLA David M. Wilson UCSF Department of Neuroradiology UC SF - PDF document

4/14/2018 SELLA David M. Wilson UCSF Department of Neuroradiology UC SF University of California, San Francisco Sella: The big 4: Macroadenoma Rathkes cleft cyst Craniopharyngioma Meningioma 1 4/14/2018 OUTLINE 1.


  1. 4/14/2018 SELLA David M. Wilson UCSF Department of Neuroradiology UC SF University of California, San Francisco Sella: The big 4: • Macroadenoma • Rathke’s cleft cyst • Craniopharyngioma • Meningioma 1

  2. 4/14/2018 OUTLINE 1. Normal anatomy & imaging 2. Adenoma and pitfalls 3. Cystic lesions OUTLINE 1. Normal anatomy & imaging 2. Adenoma and pitfalls 3. Cystic lesions 2

  3. 4/14/2018 Pituitary gland- structure www.autismpedia.org/wiki/images/e/e5/Pituitary.jpg DURA • Meningeal and periosteal layers • Continuous with dura along planum sphenoidale & clivus Capero A et al, Neurosurgery 2008; 62: 717-23 3

  4. 4/14/2018 DURA • Thin single layer along medial cavernous sinus • Double layer along lateral cavernous sinus Capero A et al, Neurosurgery 2008; 62: 717-23 UCSF Sella MRI protocol • Sagittal & coronal pregad T1 - 12 minutes TR=600ms, TE=min, NEX=3, 2.7 mm no skip • Coronal fatsat T2 FSE - 4 minutes TR=3000ms,TE=102ms, ETL=16, NEX=3, 2.0 mm no skip microadenoma • Dynamic gad T1- 45 second intervals TR=600ms, TE=17 ms, ETL=8, NEX=2, 2 mm no skip (5 slices) • Sagittal & coronal gad T1 - 12 minutes TR=800ms,TE=min,NEX=3, 2.7 mm no skip • Coronal GRE - 6 minutes hemorrhage TR=787ms, TE=25ms,NEX=2, 3 mm no skip 4

  5. 4/14/2018 Adenoma: Dynamic Gad T1 0 s 45 s • Onset: ~36 sec • Peak signal: 1.2 - 2.2 min 90s • Washout: 2.7 - 5 min 45 sec 90 sec 135 sec Dynamic enhancement • Higher time resolution but generally noisier • Estimated 10% increase* in sensitivity *Bartynski W et al, AJNR 1997; 18: 965-72 5

  6. 4/14/2018 OUTLINE 1. Normal anatomy & imaging 2. Adenoma and pitfalls 3. Cystic lesions Microadenoma • Endocrine dysfunction or incidental • Arise within the adenohypophysis • < 10 mm diameter • “ Picoadenoma ” (< 3 mm) diagnostic challenge • Rarely ectopic outside of pituitary fossa 6

  7. 4/14/2018 ?? Adenoma: T1 signal • Usually same or slightly lower signal than gland • High T1 signal if hemorrhagic (typical of prolactinoma) • Contour deformity +/- Adenoma: Enhancement • Almost all lower signal than enhanced gland • May have higher signal after 30-45 ” delay 7

  8. 4/14/2018 Adenoma: T2 signal • Usually same or slightly higher than gland ( “ soft ” ) • Less commonly lower than gland ( “ firm ” ) • Higher T2 = higher secretion 80% PRL tumors have high T2 signal 40-60% GH tumors have low T2 signal Macroadenoma • Vision changes, hypopituitarism • > 10 mm • “ Giant ” adenoma if > 4 cm • May grow in any of 6 directions Superiorly (suprasellar) - 80% of cases Laterally (cavenous sinuses) Anteriorly & inferiorly (sphenoid) Posteriorly (clivus) • Important observations Hemorrhage Optic chiasm T2 signal Cavernous sinus invasion 8

  9. 4/14/2018 T1 Signal • Heterogeneous, typically ~ gray matter • High T1 signal implies hemorrhage or another lesion T2 Signal • Highly variable - often heterogeneous, cysts and necrosis • Hemorrhage Can have any T2 signal Fluid levels helpful feature for diagnosis If hemorrhage suspected, confirm with GRE or CT 9

  10. 4/14/2018 Enhancement • Mild to avid enhancement typical • Rarely hypoenhancing (thyrotropin secreting) • Look for enhancing gland (preserved surgically) Suprasellar extension • Speculative role of diaphragmatic hiatus 10

  11. 4/14/2018 Macroadenoma: Cavernous invasion • 6-10% of adenomas • Biologically more aggressive tumors • Medial sinus has only 1 layer of dura • Clinical symptoms late • Suspect when prolactin > 1000 ng/mL Best signs of involvement • Involvement > 2/3 circumference (PPV 100%) • Carotid sulcus venous compartment (PPV 95%) • Lateral to lateral intercarotid line (PPV 85%) Cottier J-P et al, Radiology 2000; 215: 463-69 11

  12. 4/14/2018 Best signs of NO involvement (all have NPV 100%) • Involvement of < 1/4 circumference • Gland between tumor, cavernous sinus • Medial venous compartment preserved • Medial to medial intercarotid line Cottier J-P et al, Radiology 2000; 215: 463-69 Pitfalls… • 22 year-old woman, severely hypothyroid • Diagnosis: pituitary hyperplasia 12

  13. 4/14/2018 Pitfalls… • 58 year-old woman, hyperprolactinemia • Diagnosis: Tuberculum sellae meningioma Pitfalls… Optic/ hypothalamic glioma 13

  14. 4/14/2018 OUTLINE 1. Normal anatomy & imaging 2. Adenoma and pitfalls 3. Cystic lesions RATHKE CLEFT CYST • Incidental (13-22% of autopsy and MRI) or symptomatic • Non-neoplastic, single cell layered cyst arising from remnants of embryonic Rathke ’ s cleft • Natural history also slow enlargment with time 14

  15. 4/14/2018 RATHKE CLEFT CYST • Well-defined round or ovoid, thin rim enhancement • Intrasellar (40%) and/or suprasellar (60%) • Between anterior and intermediate lobes (pars intermedia) • Stalk typically midline RCC Two types 2/3 1/3 T1 bright, T2 variable T1 dark, T2 bright • “ Machine oil ” cyst • Fluid like CSF • More often symptomatic 15

  16. 4/14/2018 RCC: Useful Diagnostic Features • Arise out of pars intermedia • Midline or near midline • No displacement of stalk • Anterior to stalk if suprasellar • “ Simple ” single intensity Case: 37F panhypopit, polydipsia, vision changes 16

  17. 4/14/2018 ABSCESS • Primary (in normal gland) or secondary (in pre-exisiting adenoma or Rathke ’ s cyst) • Present like other cystic tumors, fever & meningismus rare • Source of infection hematogeous or via sphenoid sinus • Only 50% grow organisms, gram+ & gram- equally common The big third- Craniopharyngioma • Histologic continuum with RCC • Childhood type Adamantinomatous histology Poor prognosis (frequently recur) • Adult type Papillary squamous epithelium Good prognosis (rarely recur) • Mixed type Behave like adamantinomatous 17

  18. 4/14/2018 Adamantinomatous Craniopharynioma • Locations: 75% suprasellar 21% supra- and intrasellar 4% intrasellar only • Intrinsic T1 & T2 signal varies with contents of cysts (bright T1 cysts are typical) • “ Complex ” signal typical • Rule of 9 ’ s 90% mixed solid & cystic 90% enhance 90% calcify Adamantinomatous Craniopharynioma • Rule of 9 ’ s 90% mixed solid & cystic 90% enhance 90% calcify 18

  19. 4/14/2018 Case: 9 year-old with visual disturbances Diagnosis: Craniopharyngioma 19

  20. 4/14/2018 Papillary Craniopharynioma • Predominantly solid • Cysts (if present) hypointense • Spherical geometry typical CYSTIC ADENOMA • Surrounded by pituitary gland • More frequently off midline (PRL) • Variable signal intensity • Evolve over time if hemorrhagic • May bloom on GRE 20

  21. 4/14/2018 Question #1: Which of the following pineal tumors has the lowest rate of spinal metastases? A. Endodermal sinus tumor B. Germinoma C. Pineocytoma D. Pineoblastoma Question #1: Which of the following pineal tumors has the lowest rate of spinal metastases? A. Endodermal sinus tumor B. Germinoma C. Pineocytoma D. Pineoblastoma Ito et al. Pathol Int 1995 45(6): 463 Roberts et al. Am J Roentgenol 2006 186(3 supp): S224-6. Onesti et al. Clin Neurol Neurosurg 2012 114(7): 1081-5. 21

  22. 4/14/2018 Question #2: Which of the following has been reported in conjunction with NF1? A. Tectal glioma B. Craniopharyngioma C. Hypothalamic hamartoma D. Pineoblastoma Question #2: Which of the following has been reported in conjunction with NF1? A. Tectal glioma B. Craniopharyngioma C. Hypothalamic hamartoma D. Pineoblastoma Pollack et al. Neurology 1996 46(6): 1652-60 Chen et al. Oncogene 2013 (epub ahead of print) Crouse et al. Curr Top Dev Biol 2011 94: 283-308 22

  23. 4/14/2018 Question #3: Which of the following are common treatments for hypothalamic hamartoma? A. Chemotherapy B. Stereotactic radiosurgery C. Endoscopic surgery D. B and C E. A and B Question #3: Which of the following are common treatments for hypothalamic hamartoma? A. Chemotherapy B. Stereotactic radiosurgery C. Endoscopic surgery D. B and C E. A and B Wethe et al. Neurology 2013 81(12): 1044-50. Mittal et al. Neurosurg Focus 2013 34(6): E7. Choi et al. Adv Tech Stand Neurosurg 2012 39: 117-30. 23

  24. 4/14/2018 Question #4: Which of the following cell markers is 100% sensitive for choriocarcinoma? A. AFP B. hCG C. LDH D. CA-125 E. CEA Question #4: Which of the following cell markers is 100% sensitive for choriocarcinoma? A. AFP B. hCG C. LDH D. CA-125 E. CEA Jorsal et al. Acta Oncol 2012 51(1): 3-9. Kyritsis J Neurooncol 2010 96(2): 143-9. Chieffi et al. J Endocrinol Invest 35(11): 1015-20. 24

  25. 4/14/2018 Question #5: The following statement about papillary craniopharyngioma is correct: A. Seen almost exclusively in adults B. Calcification in 90% C. Higher incidence in females D. Commonly cystic E. Consists of reticular endothelial cells Question #5: The following statement about papillary craniopharyngioma is correct: A. Seen almost exclusively in adults B. Calcification in 90% C. Higher incidence in females D. Commonly cystic E. Consists of reticular endothelial cells Sartoretti-Schefer et al . AJNR 1997 18(1): 77-87 Eldevik et al. AJNR 1996 17(8): 1427-39 25

  26. 4/14/2018 THANK YOU! David.m.wilson@ucsf.ed u 26

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend